Dermatologic and Ophthalmic Drugs Advisory Committee

Results: 196



#Item
41Dermatologic and Ophthalmic Drugs Advisory Committee

Dermatologic and Ophthalmic Drugs Advisory Committee

Add to Reading List

Source URL: www.fda.gov

Language: English
42Microsoft Word - AGENDA BRUDAC_Sept 18v2.doc

Microsoft Word - AGENDA BRUDAC_Sept 18v2.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
43Federal Register / Vol. 67, No[removed]Wednesday, October 16, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting

Federal Register / Vol. 67, No[removed]Wednesday, October 16, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2002-10-16 10:10:51
44Dermatologic and Ophthalmic Drugs Advisory Committee BLA[removed] – Jetrea (ocriplasmin) intravitreal injection Wiley Chambers, M.D. Jennifer Harris, M.D.

Dermatologic and Ophthalmic Drugs Advisory Committee BLA[removed] – Jetrea (ocriplasmin) intravitreal injection Wiley Chambers, M.D. Jennifer Harris, M.D.

Add to Reading List

Source URL: www.fda.gov

Language: English
45Staff Manual Guide[removed]

Staff Manual Guide[removed]

Add to Reading List

Source URL: www.fda.gov

Language: English
46Food and Drug Administration Center for Drug Evaluation and Research Division of Transplant and Ophthalmology Products Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Briefing Package

Food and Drug Administration Center for Drug Evaluation and Research Division of Transplant and Ophthalmology Products Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Briefing Package

Add to Reading List

Source URL: www.fda.gov

Language: English
47Anti-Inflammatory Drugs for Post-operative Indications Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) February 27, 2012 Renata Albrecht, MD

Anti-Inflammatory Drugs for Post-operative Indications Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) February 27, 2012 Renata Albrecht, MD

Add to Reading List

Source URL: www.fda.gov

Language: English
48Dermatologic and Ophthalmic Drugs Advisory Committee Meeting BLA[removed]for Lucentis (ranibizumab injection) Rhea A. Lloyd, M.D. US Food and Drug Administration

Dermatologic and Ophthalmic Drugs Advisory Committee Meeting BLA[removed]for Lucentis (ranibizumab injection) Rhea A. Lloyd, M.D. US Food and Drug Administration

Add to Reading List

Source URL: www.fda.gov

Language: English
49Microsoft Word - Tables-Where can I go for help.doc

Microsoft Word - Tables-Where can I go for help.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
50Microsoft Word - iPLEDGE AM backgrounder FINAL.doc

Microsoft Word - iPLEDGE AM backgrounder FINAL.doc

Add to Reading List

Source URL: www.fda.gov

Language: English